CORE News banner

Breadcrumb

Asset Publisher

Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

COVID-19 pandemic: the need for privacy and digital contact tracing

RI-MUHC researcher Abhinav Sharma calls for an approach emphasizing voluntary consent

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

Why do some non-smokers get COPD while many heavy smokers don’t?

A new study highlights a strong risk factor for COPD related to lung development

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

Results of MI4 Emergency COVID-19 Research Funding (Round 2)

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

National study to collect data on aging adults’ experiences during COVID-19 pandemic

Christina Wolfson is co-principal investigator on a new national study

RI-MUHC researchers review diagnostic tests for COVID-19

Study published in the Annals of Internal Medicine

Results of MI4 Emergency COVID-19 Research Funding (Round 1)

RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe

RI-MUHC innovative clinical trial assesses hydroxychloroquine for prevention and treatment of COVID-19

Initially restricted to health care workers in Quebec, the clinical study is now open to all eligible adults

COVID-19 coronavirus and tuberculosis: We need a damage control plan

Dr. Madhukar Pai explains why TB services might be one of the biggest casualties of the pandemic

Maida Sewitch honoured by Canadian Association of Gastroenterology

Epidemiologist who conducted some of the first Canadian studies in colorectal cancer screening has a talent for outreach

RI-MUHC researcher part of federally-funded COVID-19 research initiative

David Buckeridge is one of 47 Canadian researchers chosen to contribute to the global response

RI-MUHC researcher on Innovation Panel at the U.S. National Academy of Sciences

Dr. Nitika Pant Pai speaks out on global microbial threats

See Archive - Core News